Preclinical Alzheimer's Disease Clinical Trial
Official title:
AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study With an Extension Phase to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer's Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer's Disease and Intermediate Amyloid (A3 Trial)
The primary purpose of this study is to determine whether treatment with lecanemab is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Trial) and to determine whether treatment with lecanemab is superior to placebo in reducing brain amyloid accumulation as measured by amyloid positron emission tomography (PET) at 216 weeks of treatment (A3 Trial). This study will also evaluate the long-term safety and tolerability of lecanemab in participants enrolled in the Extension Phase.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06033066 -
Financial Incentives and Recruitment to the APT Webstudy
|
N/A | |
| Enrolling by invitation |
NCT06416072 -
Alzheimer's Plasma Extension
|
||
| Recruiting |
NCT04851496 -
Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - PAST Extension
|
||
| Terminated |
NCT04846426 -
Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension
|
||
| Completed |
NCT04828122 -
Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech
|
||
| Completed |
NCT02045056 -
Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease
|
Early Phase 1 | |
| Completed |
NCT03370744 -
Prediction of Cognitive Decline by Neuroimaging Techniques and the Application in Diagnosis and Treatment of Preclinical AD
|
||
| Completed |
NCT02963415 -
Concurrent Aerobic Exercise and Virtual Reality Cognitive Training
|
N/A | |
| Active, not recruiting |
NCT04004767 -
TRC-PAD Program: In-Clinic Trial-Ready Cohort
|
||
| Recruiting |
NCT04937959 -
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension
|
||
| Completed |
NCT04928976 -
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping
|
||
| Terminated |
NCT04951284 -
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension
|